Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Therapeutic peptides are emerging as promising drug candidates, garnering significant attention in the field of medicine and drug development due to their high specificity, affinity, and low toxicity [1-3]
Figure 3 Figure 4 illustrates the diverse therapeutic targets of novel agents currently under investigation for ulcerative colitis, depicting their sites of action across the intestinal mucosa, vasculature, lymphoid tissue, and intracellular signaling pathways involved in inflammation and immune cell trafficking
It is not legally available for prescription use in the United States outside of an active clinical trial
Tirzepatide works by binding to and activating the GLP-1 and GIP receptors, resulting in the release of insulin and inhibition of glucagon secretion
